Case File 03 · Cohort Report

Beyond ovarian decline

Perimenopause and menopause may reveal pre-existing physiological fragility, rather than cause it outright. An observational read of women across five biological reserves, before symptoms are written off as "just menopause."

Cohort
Up to 130 women
Age Range
36-60 years
Design
Cross-sectional, observational

Perimenopause and menopause may reveal pre-existing physiological fragility, not simply cause metabolic decline.

Five reserves, assessed together

Rather than reading midlife decline through ovarian hormones alone, this framework evaluates five interdependent reserves, because a woman can look "normal" on any single marker while several reserves are already running low.

What the panels showed

Metabolic Reserve
Fasting insulin >7 µIU/mL (mean ~9.4); 44.1% exceeded 10 µIU/mL despite normal fasting glucose.
58.8%
Anabolic Reserve
Creatinine <0.7 mg/dL (47.1%) and BUN <10 mg/dL (51.4%), alongside histories of low protein intake and minimal resistance training.
51.4%
Androgen Reserve
DHEAS <100 µg/dL in 60.9% of the cohort; 43.5% fell below 75 µg/dL.
60.9%
Vascular-Metabolic Context
Homocysteine >10 µmol/L in 68.6% of the cohort; mean 12.3 µmol/L.
68.6%
Nutrient Reserve
Ferritin <30 ng/mL in 50.0%; 61.8% fell below 50 ng/mL.
61.8%

Ovarian, anabolic, metabolic, nutrient, recovery

01

Ovarian reserve

The conventional lens, insufficient alone to explain the range of symptoms seen across the cohort.

02

Anabolic reserve

Muscle-protein turnover capacity, tracked through creatinine and BUN alongside training and protein history.

03

Metabolic reserve

Insulin sensitivity assessed beyond fasting glucose alone, where most dysfunction was hiding.

04

Nutrient reserve

Iron and related stores, frequently depleted well before symptoms are attributed to menopause.

05

Recovery reserve

Vascular and inflammatory context (including homocysteine) that shapes how well the body tolerates the transition.

Documented Limitations

  • Selection bias: the cohort draws from an optimization-seeking population, not a general population sample.
  • Variable denominators across biomarkers; not every marker was run on every woman.
  • Cross-sectional, not prospective. This is a snapshot, not a tracked trajectory.
  • No direct muscle mass or strength measurements were taken.

Menopause is often the moment fragility becomes visible, not the moment it began. The five reserves are where a strategy should start looking, well before that moment arrives.